Page last updated: 2024-11-13

mirincamycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Cross-References

ID SourceID
PubMed CID134129858
CHEMBL ID3990947
MeSH IDM0040829

Synonyms (2)

Synonym
mirincamycin
CHEMBL3990947

Research Excerpts

Bioavailability

ExcerptReferenceRelevance
" cis-Mirincamycin had an absolute oral bioavailability of 13."( Absolute bioavailability of cis-mirincamycin and trans-mirincamycin in healthy rhesus monkeys and ex vivo antimalarial activity against Plasmodium falciparum.
Fracisco, S; Imerbsin, R; Khemawoot, P; Melendez, V; Ohrt, C; Rasameesoraj, M; Saunders, D; Teja-Isavadharm, P, 2011
)
0.37

Dosage Studied

ExcerptRelevanceReference
" Fourteen male rhesus monkeys were randomized to four groups, which included cis and trans isomers by the oral and intravenous routes, with vehicle-only controls for each dosing route."( Absolute bioavailability of cis-mirincamycin and trans-mirincamycin in healthy rhesus monkeys and ex vivo antimalarial activity against Plasmodium falciparum.
Fracisco, S; Imerbsin, R; Khemawoot, P; Melendez, V; Ohrt, C; Rasameesoraj, M; Saunders, D; Teja-Isavadharm, P, 2011
)
0.37
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (28.57)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's4 (57.14)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]